New Century Financial Group LLC Buys 854 Shares of Sanofi (NASDAQ:SNY)

New Century Financial Group LLC boosted its stake in shares of Sanofi (NASDAQ:SNY) by 20.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,108 shares of the company’s stock after purchasing an additional 854 shares during the quarter. New Century Financial Group LLC’s holdings in Sanofi were worth $248,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC grew its holdings in Sanofi by 17.9% in the first quarter. Sivia Capital Partners LLC now owns 7,199 shares of the company’s stock worth $350,000 after purchasing an additional 1,091 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in Sanofi by 773.4% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 5,651 shares of the company’s stock valued at $275,000 after buying an additional 5,004 shares in the last quarter. Park Place Capital Corp raised its stake in Sanofi by 6.3% in the first quarter. Park Place Capital Corp now owns 9,068 shares of the company’s stock valued at $441,000 after buying an additional 534 shares during the last quarter. BKM Wealth Management LLC boosted its holdings in Sanofi by 74.3% in the first quarter. BKM Wealth Management LLC now owns 8,314 shares of the company’s stock worth $404,000 after acquiring an additional 3,543 shares in the last quarter. Finally, First Bank & Trust grew its stake in shares of Sanofi by 24.1% during the first quarter. First Bank & Trust now owns 35,855 shares of the company’s stock worth $1,743,000 after acquiring an additional 6,968 shares during the last quarter. Institutional investors own 10.04% of the company’s stock.

Sanofi Stock Performance

SNY opened at $48.86 on Friday. The company has a market cap of $123.75 billion, a P/E ratio of 24.55, a price-to-earnings-growth ratio of 1.51 and a beta of 0.59. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The firm’s 50-day moving average price is $48.73 and its 200-day moving average price is $48.58. Sanofi has a 52-week low of $42.63 and a 52-week high of $55.72.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The business had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. As a group, equities analysts anticipate that Sanofi will post 4.14 EPS for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.